跳至主要内容
临床试验/NCT06858345
NCT06858345招募中不适用

Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Prolongation of at least one week of gestation in pregnancy complicated by hypertensive state of pregnancy with antihypertensive therapy guided by hemodynamic phenotypes

研究概览

简要总结

The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Age greater than or equal to 18 years
  • •Women with singleton and twin pregnancies complicated by hypertensive states of pregnancy.

排除标准

  • •Minors under 18 years of age.
  • •Women with mental disabilities.
  • •Major congenital fetal anomaly.

结局指标

主要结局

Prolongation of at least one week of gestation in pregnancy complicated by hypertensive state of pregnancy with antihypertensive therapy guided by hemodynamic phenotypes

时间窗: Up to 40 weeks

Number of weeks of pregnancy

次要结局

未报告次要终点

研究者

发起方
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

尚未招募
不适用
Biomarkers of CVD Dysfunction in Hypertensive Disorders of PregnancyPregnancyCardiovascular Diseases
NCT05806372IRCCS Burlo Garofolo128
进行中(未招募)
不适用
Maternal, uteroplacental and fetal haemodynamic effect of Nicardipine in severe pre-eclampsia. - CORCA IIHypertensive crisis in patients with severe pre-eclampsia needs to be treated to prevent maternal and fetal complications. The maternal, uteroplacental and fetal haemodynamic respose to antihypertensive treatment with Nicardipinehydrochloride will be evaluated in detail by materal echocardiography and fetal doppler ultrasound as well as by the effect on plasma Brain Natriuretic Peptide concentration (BNP) and parameters of the Renin- Angiotensin- Aldosterone system (RAAS).MedDRA version: 9.1Level: LLTClassification code 10040445Term: Severe pre-eclampsia, antepartumMedDRA version: 9.1Level: LLTClassification code 10053094Term: Doppler echocardiographyMedDRA version: 9.1Level: LLTClassification code 10045412Term: Ultrasound DopplerMedDRA version: 9.1Level: LLTClassification code 10058179Term: Hypertensive emergencyMedDRA version: 9.1Level: LLTClassification code 10038555Term: ReninMedDRA version: 9.1Level: LLTClassification code 10002491Term: Angiotensin IIMedDRA version: 9.1Level: LLTClassification code 10053406Term: Brain natriuretic peptideMedDRA version: 9.1Level: LLTClassification code 10001644Term: Aldosterone
EUCTR2007-000727-17-NLErasmus MC10
已完成
不适用
Evaluation of Fetal Cardiac Function in Rheumatic Heart Disease (RHD) PatientsFetal Distress
NCT03095937Assiut University152
已完成
不适用
Assessment of Cardiac Sparing in Fetal HypoxiaFetal Hypoxia
NCT03146507Assiut University210
Unknown
不适用
Vascular Changes in Pre-Eclamptic Patients and Its Impact on Pregnancy Outcome.Pre-Eclampsia
NCT03111576Beni-Suef University100